Skip to main content
SpringerLink
Log in

Chemical construction of immunotoxins

  • Protocol
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Immunotoxins are chimeric proteins consisting of an antibody linked to a toxin. The antibodies most frequently used for the preparation of immunotoxins are murine monoclonal antibodies belonging to IgG isotype. The most used toxins for the chemical construction of immunotoxins are Ricin toxin A chain in its deglycosylated form and recombinant Pseudomonas endotoxin with the cell-binding domain deleted. The linkage of the antibody to the toxin can be accomplished by chemical methods using reagents that crosslink antibody to toxin. The usual crosslinkers attach disulfide groups into the antibody molecule to form a disulfide bond between the antibody and the toxin. Disulfide bonds are susceptible to reduction in the cytoplasm of the targeted cells thereby releasing the toxin so that it can exert its cytotoxic activity only into the cells (e.g., tumor cells) binding the antibody moiety.

This article describes various methods to obtain antibodies and toxins and several procedures for their crosslinking as well as “in vitro” and “in vivo” testing of the immunotoxins efficacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ghetie, V. and Vitetta, E. S. (1994) Immunotoxins in the therapy of cancer: from bench to clinic. Pharmacol. Ther. 63(3), 209–234.

    Article  PubMed  CAS  Google Scholar 

  2. Thrush, G. R., Lark, L. R., and Vitetta, E. S. (1996) Immunotoxins (review), in Therapeutic Immunology (Austen, K. F., Burakoff, S. J., Rosen, F. S., and Strom, T. B., eds.), Blackwell Science, Boston, pp. 385–397.

    Google Scholar 

  3. Pai, L. H. and Pastan, I. (1993) Immunotoxin therapy for cancer. JAMA 269, 78–81.

    Article  PubMed  CAS  Google Scholar 

  4. Frankel, A. E., Tagge, E. P., and Willingham, M. C. (1995) Clinical trials of targeted toxins, Semin. Cancer Biol. 6, 307–317.

    Article  PubMed  CAS  Google Scholar 

  5. Ghetie, M. A. and Vitetta, E. S. (1994) Recent developments in immunotoxin therapy. Curr. Opin. Immunol. 6, 707–714.

    Article  PubMed  CAS  Google Scholar 

  6. Grossbard, M. and Nadler, L. M. (1994) Immunotoxin therapy of lymphoid neoplasms. Semin. Hematol. 31, 88–97.

    PubMed  CAS  Google Scholar 

  7. Wong, S. S. (1991) Chemistry of Protein Conjugation and Cross-Linking. CRC, Boca Raton, FL, pp. 267–294.

    Google Scholar 

  8. Vitetta, E. S., Thorpe, P. E., and Uhr, J. W. (1993) Immunotoxins: magic bullets or misguided missiles. Trends Pharmacol. Sci. 14, 148–154.

    Article  PubMed  CAS  Google Scholar 

  9. Brinkmann, U. and Pastan, I. (1994) Immunotoxins against cancer. Biochim. Biophys. Acta 1198, 27–45.

    PubMed  CAS  Google Scholar 

  10. Kreitman, R. J. and Pastan, I. (1994) Recombinant toxins. Adv. Pharmacol. 28, 193–219.

    Article  PubMed  CAS  Google Scholar 

  11. Carlsson, J., Drevin, H., and Axen, R. (1978) Protein thiolation and reversible protein-protein conjugation N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem. J. 173(3), 723–737.

    PubMed  CAS  Google Scholar 

  12. Brinkley, M. A. (1992) A survey of methods for preparing protein conjugates with dyes, haptens and crosslinking reagents. Bioconjug. Chem. 3, 2–13.

    Article  PubMed  CAS  Google Scholar 

  13. Thorpe, P. E., Wallace, P. M., Knowles, P. P., Relf, M. G., Brown, A. N. F., Watson, G. J., et al. (1988) Improved anti-tumor effects of immunotoxins prepared with deglycosylated ricin A chain and hindered disulfide linkages. Cancer Res. 48, 6396–6403.

    PubMed  CAS  Google Scholar 

  14. FitzGerald, D., Idziorek, T., Bartra, J. K., Willingham, M., and Pastan, I. (1990) Antitumor activity of a thioether-linked immunotoxin: OVB3-PE. Bioconjug. Chem. 1, 264–268.

    Article  PubMed  CAS  Google Scholar 

  15. Lambert, J. M., Goldmacher, V. S., Collinson, A. R., Nadler, L. M., and Blattler, W. A. (1991) An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use. Cancer Res. 51, 6236–6242.

    PubMed  CAS  Google Scholar 

  16. Harris, W. J. and Cunningham, C. (1995) Antibody Therapeutics. Landis, Austin, TX.

    Google Scholar 

  17. Goding, J. W. (1996) Monoclonal Antibodies: Principles and Practices. Academic, London, pp. 192–227.

    Google Scholar 

  18. Lamoyi, E. and Nisonoff, A. (1983) Preparation of F(ab′)2 fragments from mouse IgG of various subclasses. J. Immunol. Methods 50, 234–243.

    Google Scholar 

  19. Parham, P. (1983) On the fragmentation of monoclonal IgG1, IgG2a and IgG2b from BALB/c mice. J. Immunol. 131, 2895–2902.

    PubMed  CAS  Google Scholar 

  20. Ghetie, V., Ghetie, M., Uhr, J. W., and Vitetta, E. S. (1988) Large scale preparation of immunotoxins constructed with the Fab′ fragment of IgG1 murine monoclonal antibodies and chemically deglycosylated ricin A chain. J. Immunol. Methods 112, 267–277.

    Article  PubMed  CAS  Google Scholar 

  21. Thorpe, P. E., Wallace, P. M., Knowles, P. P., Relf, M. G., Brown, A. N. F., Watson, G. J., et al. (1987) New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res. 47, 5924–5931.

    PubMed  CAS  Google Scholar 

  22. Thorpe, P. E., Blakey, D. C., Brown, A. N., Knowles, P. P., Knyba, R. E., Wallace, P. M., et al. (1987) Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants. J. Natl. Cancer Inst. 79, 1101–1112.

    PubMed  CAS  Google Scholar 

  23. Ghetie, V., Thorpe, P. E., Ghetie, M., Knowles, P., Uhr, J. W., and Vitetta, E. S. (1991) The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond. J. Immunol. Methods 142, 223–230.

    Article  PubMed  CAS  Google Scholar 

  24. Lambert, J. M., Blattler, W. A., McIntyre, G. D., Goldmacher, V. S., and Scott, C. F., Jr. (1988) Immunotoxins containing single chain ribosome-inactivating proteins, in Immunotoxins (Franker, A. E., ed.), Kluwer, Norwell, MA, pp. 175–213.

    Google Scholar 

  25. Duncan, R. J., Weston, P. D., and Wrigglesworth, R. (1983) A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal. Biochem. 132, 68–73.

    Article  PubMed  CAS  Google Scholar 

  26. Hashida, S., Imagawa, M., Inque, S., Ruan, K. H., and Ishikawa, E. (1983) More useful maleimide compounds for the conjugation of Fab to horseradish peroxidase through thiol groups in the hinge. J. Appl. Biochem. 6, 56–63.

    Google Scholar 

  27. Lambert, J. M., McIntyre, G., Gauthier, M. N., Zullo, D., Rao, V., Steeves, R. M., et al. (1997) The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides. Biochemistry 30, 3234–3247.

    Article  Google Scholar 

  28. Thorpe, P. E., Detre, S. I., Foxwell, B. M. J., Brown, A. N. F., Skilleter, D. N., Wilson, G., et al. (1985) Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution. Eur. J. Biochem. 147, 197–206.

    Article  PubMed  CAS  Google Scholar 

  29. Ghetie, M., May, R. D., Till, M., Uhr, J. W., Ghetie, V., Knowles, P. P., et al. (1988) Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy. Cancer Res. 48, 2610–2617.

    PubMed  CAS  Google Scholar 

  30. Ghetie, V., Till, M. A., Ghetie, M., Tucker, T., Porter, J., Patzer, E. J., et al. (1990) Preparation and characterization of conjugates of recombinant CD4 and deglycosylated ricin A chain using different cross-linkers. Bioconjug Chem. 1, 24–31.

    Article  PubMed  CAS  Google Scholar 

  31. Fulton, R. J., Blakey, D. C., Knowles, P. P., Uhr, J. W., Thorpe, P. E., and Vitetta, E. S. (1986) Production of ricin A1, A2, and B chains and characterization of their toxicity. J. Biol. Chem. 261, 5314–5319.

    PubMed  CAS  Google Scholar 

  32. Irvin, J. D. (1983) Pokeweed antiviral protein. Pharmacol. Ther. 21, 371–387.

    Article  PubMed  CAS  Google Scholar 

  33. Irvin, J. D. and Uckun, F. M. (1997) Pokeweed antiviral protein: Ribosome inactivation and therapeutic applications. Pharmacol. Ther. 55, 279–302.

    Article  Google Scholar 

  34. Myers, D. E., Irvin, J. D., Smith, R. S., Kuebelbeck, V. M., and Uckun, F. M. (1991) Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials. J. Immunol. Methods 136, 221–237.

    Article  PubMed  CAS  Google Scholar 

  35. Ogata, M., Chaudhary, V. K., Pastan, I., and Fitzgerald, D. J. (1997) Processing of pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol. J. Biol. Chem. 265, 20,678–20,685.

    Google Scholar 

  36. Allured, V. S., Collier, R. J., Carroll, S. F., and McKay, D. B. (1986) Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. Proc. Natl. Acad. Sci. USA 83, 1320–1324.

    Article  PubMed  CAS  Google Scholar 

  37. Hwang, J., FitzGerald, D. J., Adhya, S., and Pastan, I. (1987) Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 48, 129–136.

    Article  PubMed  CAS  Google Scholar 

  38. Kreitman, R. J., Hansen, H. J., Jones, A. L., Fitz-Gerald, D. J. P., Goldenberg, D. M., and Pastan, I. (1993) Pseudomonas exotoxin-based immunotoxins containing the antibody LL2 or LL2-Fab′ induce regression of subcutaneous human B-cell lymphoma in mice. Cancer Res. 53, 819–825.

    PubMed  CAS  Google Scholar 

  39. Mansfield, E., Pastan, I., FitzGerald, D. J. (1996) Characterization of RFB4—Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies. Bioconjug. Chem. 7, 557–563.

    Article  PubMed  CAS  Google Scholar 

  40. Ghetie, V., Swindell, E., Uhr, J. W., and Vitetta, E. S. (1993) Purification and properties of immunotoxins containing one vs two deglycosylated ricin A chain. J. Immunol. Methods 166, 117–122.

    Article  PubMed  CAS  Google Scholar 

  41. Ghetie, V., Engert, A., Schnell, R., and Vitetta, E. S. (1995) The in vivo anti-tumor activity of immunotoxins containing two vs one deglycosylated ricin A chains. Cancer Lett. 98(1), 97–101.

    Article  PubMed  CAS  Google Scholar 

  42. Fraker, P. J. and Speck, J. C., Jr. (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849–857.

    Article  PubMed  CAS  Google Scholar 

  43. Ghetie, M. A., Richardson, J., Tucker, T., Jones, D., Uhr, J. W., and Vitetta, E. S. (1990) Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice. Int. Cancer 45, 481–485.

    Article  CAS  Google Scholar 

  44. Ghetie, M. A., Richardson, J., Tucker, T., Jones, D., Uhr, J. W., and Vitetta, E. S. (1991) Antitumor activity of Fab′ and IgG-anti-CD22 immunotoxins in disseminated human B lymphomas grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites. Cancer Res. 51, 5876–5880.

    PubMed  CAS  Google Scholar 

  45. Ghetie, M. A., Tucker, K., Richardson, J., Uhr, J. W., and Vitetta, E. S. (1992) The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD 19 immunotoxin. Blood 80, 2315–2320.

    PubMed  CAS  Google Scholar 

  46. Uckun, F. M., Ramakrishnan, S., and Houston, L. L. (1985) Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. J. Immunol. 134, 2010–2016.Fig. 2. Covalent bonds crosslinking antibody to toxin.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Immunobiology Center, Southwestern Medical Center, 5323 Harry Hines Blvd., 75390-8576, Dallas, TX

    Victor Ghetie

Authors
  1. Victor Ghetie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ellen S. Vitetta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Victor Ghetie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghetie, V., Vitetta, E.S. Chemical construction of immunotoxins. Mol Biotechnol 18, 251–268 (2001). https://doi.org/10.1385/MB:18:3:251

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/MB:18:3:251

Index Entries

Search

Navigation